Media Summary: 6-month DAPT post coronary stenting. For more resources from the Rosk/Benefit of prolonged DAPT after DES. For more resources from the Losartan In Hypertrophic Cardiomyopathy. For more resources from the
Ehj Today The Italic Trial - Detailed Analysis & Overview
6-month DAPT post coronary stenting. For more resources from the Rosk/Benefit of prolonged DAPT after DES. For more resources from the Losartan In Hypertrophic Cardiomyopathy. For more resources from the Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Post MI remodeling and HFpEF. For more resources from the Aspirin and primary prevention of cardiovascular events in the elderly exposed to multiple atherosclerotic risk factors. For more ...
... this decades that we have passed through obviously the therapies that we use FOCUS: Fixed-dose combination drug for secondary cardiovascular prevention. Alirocumab vs Ezetimibe in patients with statin intolerance. For more resources from the Investigation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. For more resources from the Effect of ferric carboxymaltose on functional capacity in patients with HF and iron deficiency. Thomas Lüscher, Professor and Chairman of Cardiology at the University Hospital Zurich and Editor-in-Chief of the
